DIRECTOR, REGULATORY AFFAIRS - CMC

IT SUPPORT SPECIALIST II

SENIOR MANAGER, STATISTICAL PROGRAMMING

SENIOR MANAGER/ASSOCIATE DIRECTOR, BIOSTATISTICS

SENIOR SCIENTIST I/II, NGS & MOLECULAR BIOLOGY

SCIENTIST/SENIOR SCIENTIST, EPITOPE & TCR DISCOVERY

OFFICE MANAGER and EXECUTIVE ASSISTANT

VICE PRESIDENT, CLINICAL DEVELOPMENT (MD) - INFECTIOUS DISEASE

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

AIRNA Bio

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Theranostics

Alphabioregen

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

Alveolus Bio

ALX Oncology

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AN2 Therapeutics

Anagram Therapeutics

Andes

Angiex

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Anokion

Ansa Biotechnologies

Antheia

Anthos Therapeutics

AOA Dx

Apic Bio

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Aramis Biosciences

Arbor Biotechnologies

Arcadia Science

Arcellx

Arctoris

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Gritstone bio is developing immunotherapies for cancer and infectious diseases. Immunotherapies work by activating the patient's immune response - for instance, activating T cells to detect and eliminate cancerous or infected cells. Gritstone is creating a diverse portfolio of immunotherapies using their EDGE platform, an AI-driven platform that can identify T cell targets on tumor or virally infected cells. Gritstone then uses their immunogenic vaccine platform to stimulate the immune system and drive generation of T cells and antibodies against the identified targets. Their portfolio includes two key classes of products. Individualized products that are unique to an individual patient and ‘off-the-shelf’ products that target cancer mutations that recur between different cancer patients. Gritstone is also working on a COVID-19 vaccine to provide longer, more robust immunity to emerging variants.

<p>Gritstone bio is developing immunotherapies for cancer and infectious diseases. Immunotherapies work by activating the patient&#39;s immune response - for instance, activating T cells to detect and eliminate cancerous or infected cells. Gritstone is creating a diverse portfolio of immunotherapies using their EDGE platform, an AI-driven platform that can identify T cell targets on tumor or virally infected cells. Gritstone then uses their immunogenic vaccine platform to stimulate the immune system and drive generation of T cells and antibodies against the identified targets. Their portfolio includes two key classes of products. Individualized products that are unique to an individual patient and ‘off-the-shelf’ products that target cancer mutations that recur between different cancer patients. Gritstone is also working on a COVID-19 vaccine to provide longer, more robust immunity to emerging variants.</p>


Find a biotech startup job.